Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis

Chronic oleoylethanolamide treatment improves spatial cognitive deficits through enhancing hippocampal neurogenesis after transient focal cerebral ischemia

(2015) Li-chao Yang et al.   BIOCHEMICAL PHARMACOLOGY

Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells

(2015) Massimo Barbierato et al.   Scientific Reports

Harnessing the anti-inflammatory potential of palmitoylethanolamide

(2014) Mireille Alhouayek et al.   DRUG DISCOVERY TODAY

Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease

(2013) Caterina Scuderi et al.   CNS & Neurological Disorders-Drug Targets

The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism

(2013) Ramiro Gonzalez-Aparicio et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Necrotizing skin lesion and radial nerve palsy in a patient treated with glatiramer acetate

(2013) Antonio Carotenuto et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Progesterone reverts LPS-reduced FAAH activity in murine peripheral blood mononuclear cells by a receptor-mediated fashion

(2013) Manuel L. Wolfson et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6

(2013) M. Alhouayek et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Regulation of CCL20 expression in astrocytes by IL-6 and IL-17

(2012) Gordon P. Meares et al.   GLIA

The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α

(2012) Shu Zhu et al.   NATURE MEDICINE

Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α

(2012) Yu Zhou et al.   NEUROPHARMACOLOGY

Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease

(2012) Giuseppe D'Agostino et al.   NEUROPSYCHOPHARMACOLOGY

Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis

(2012) Peter L. Foley et al.   PAIN

Epigenetic Regulation of Fatty Acid Amide Hydrolase in Alzheimer Disease

(2012) Claudio D'Addario et al.   PLoS One

Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series

(2012) Jan Keppel Hesselink et al.   Journal of Pain Research

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury

(2011) Emanuela Esposito et al.   BRAIN BEHAVIOR AND IMMUNITY

Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation

(2011) Greta Guarda et al.   IMMUNITY

IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease

(2011) Jarod Zepp et al.   TRENDS IN IMMUNOLOGY

Endocannabinoid biosynthesis and inactivation, from simple to complex

(2010) Giulio G. Muccioli   DRUG DISCOVERY TODAY

Análisis del dolor en pacientes con esclerosis múltiple

(2010) L. Grau-López et al.   NEUROLOGIA

Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain

(2009) Kay Ahn et al.   CHEMISTRY & BIOLOGY

Interferon-β treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1

(2009) George P. Christophi et al.   CLINICAL IMMUNOLOGY

Regulatory effects of IFN-β on production of osteopontin and IL-17 by CD4+ T Cells in MS

(2009) Meiyue Chen et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-κB nuclear signalling in dorsal root ganglia

(2009) Giuseppe D'Agostino et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Grey matter pathology in clinically early multiple sclerosis: Evidence from magnetic resonance imaging

(2009) Declan Chard et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation

(2009) C. Solorzano et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells

(2008) Fernando Correa et al.   BIOCHEMICAL PHARMACOLOGY

The Endocannabinoid System in Peripheral Lymphocytes as a Mirror of Neuroinflammatory Diseases

(2008) Diego Centonze et al.   CURRENT PHARMACEUTICAL DESIGN

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

(2008) Frida Loría et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT)

(2008) C. Forn et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

Mechanisms of inflammation induced tissue injury in multiple sclerosis

(2008) Hans Lassmann   JOURNAL OF THE NEUROLOGICAL SCIENCES

Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study

(2008) Massimiliano Calabrese et al.   NEUROIMAGE

Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease

(2007) Tiziana Bisogno et al.   NEUROCHEMISTRY INTERNATIONAL

Pain associated with multiple sclerosis: Systematic review and proposed classification

(2007) Alec B. O’Connor et al.   PAIN